Cargando…
Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes
The prevalence of diabetes mellitus (DM) has dramatically increased in the past decade. Furthermore, increasing evidence from research shows that oxidative stress (OS) plays a crucial role in the pathogenesis of diabetes and in its complications. A search for ways to reduce oxidative damage has beco...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355006/ https://www.ncbi.nlm.nih.gov/pubmed/28911467 http://dx.doi.org/10.1016/j.jfda.2014.04.001 |
_version_ | 1784763197160423424 |
---|---|
author | Spadiene, Asta Savickiene, Nijole Ivanauskas, Liudas Jakstas, Valdas Skesters, Andrejs Silova, Alise Rodovicius, Hiliaras |
author_facet | Spadiene, Asta Savickiene, Nijole Ivanauskas, Liudas Jakstas, Valdas Skesters, Andrejs Silova, Alise Rodovicius, Hiliaras |
author_sort | Spadiene, Asta |
collection | PubMed |
description | The prevalence of diabetes mellitus (DM) has dramatically increased in the past decade. Furthermore, increasing evidence from research shows that oxidative stress (OS) plays a crucial role in the pathogenesis of diabetes and in its complications. A search for ways to reduce oxidative damage has become the focus of interest for the majority of scientists. In this study, we determined the radical scavenging activity of single green tea constituents by using an on-line high performance liquid chromatography (HPLC)–2,2-diphenyl-1-picrylhydrazyl (DPPH) method and evaluated the antioxidant effects on type 2 diabetic patients by performing a double-blind, placebo-controlled study. Epigallocatechin gallate was identified as the most potent antioxidant, contributing approximately 50% of the total antioxidant capacity of green tea extract. We also found a statistically significant decrement of lipid peroxidation markers in patients treated with green tea extract after 9 months or after 18 months of follow-up. Overall, these findings are attractive for diabetic patients, helping them to keep a high level of performance and well-being, which ultimately may delay the time of disability and reduce mortality. |
format | Online Article Text |
id | pubmed-9355006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Taiwan Food and Drug Administration |
record_format | MEDLINE/PubMed |
spelling | pubmed-93550062022-08-09 Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes Spadiene, Asta Savickiene, Nijole Ivanauskas, Liudas Jakstas, Valdas Skesters, Andrejs Silova, Alise Rodovicius, Hiliaras J Food Drug Anal Original Article The prevalence of diabetes mellitus (DM) has dramatically increased in the past decade. Furthermore, increasing evidence from research shows that oxidative stress (OS) plays a crucial role in the pathogenesis of diabetes and in its complications. A search for ways to reduce oxidative damage has become the focus of interest for the majority of scientists. In this study, we determined the radical scavenging activity of single green tea constituents by using an on-line high performance liquid chromatography (HPLC)–2,2-diphenyl-1-picrylhydrazyl (DPPH) method and evaluated the antioxidant effects on type 2 diabetic patients by performing a double-blind, placebo-controlled study. Epigallocatechin gallate was identified as the most potent antioxidant, contributing approximately 50% of the total antioxidant capacity of green tea extract. We also found a statistically significant decrement of lipid peroxidation markers in patients treated with green tea extract after 9 months or after 18 months of follow-up. Overall, these findings are attractive for diabetic patients, helping them to keep a high level of performance and well-being, which ultimately may delay the time of disability and reduce mortality. Taiwan Food and Drug Administration 2014-05-20 /pmc/articles/PMC9355006/ /pubmed/28911467 http://dx.doi.org/10.1016/j.jfda.2014.04.001 Text en © 2014 Taiwan Food and Drug Administration https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Original Article Spadiene, Asta Savickiene, Nijole Ivanauskas, Liudas Jakstas, Valdas Skesters, Andrejs Silova, Alise Rodovicius, Hiliaras Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes |
title | Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes |
title_full | Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes |
title_fullStr | Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes |
title_full_unstemmed | Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes |
title_short | Antioxidant effects of Camellia sinensis L. extract in patients with type 2 diabetes |
title_sort | antioxidant effects of camellia sinensis l. extract in patients with type 2 diabetes |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355006/ https://www.ncbi.nlm.nih.gov/pubmed/28911467 http://dx.doi.org/10.1016/j.jfda.2014.04.001 |
work_keys_str_mv | AT spadieneasta antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes AT savickienenijole antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes AT ivanauskasliudas antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes AT jakstasvaldas antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes AT skestersandrejs antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes AT silovaalise antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes AT rodoviciushiliaras antioxidanteffectsofcamelliasinensislextractinpatientswithtype2diabetes |